chartexchange

Forget Zepbound: 3 Newer Drugs That Could Power Eli Lilly's Next Leg Higher

The Motley Fool | Oct 16, 2026 2:58 PM EDT


Key PointsEli Lilly could continue to dominate the weight-loss market thanks to medicines like Foundayo and retatrutide.

Read original article